Short synopsis of facts about The Jackson Laboratory
OVERVIEW
The Jackson Laboratory is an independent, 501(c)3 nonprofit biomedical research institution founded in 1929 in Bar Harbor, Maine.
Our mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.
We are a global team of nearly 3,000 people at 11 locations in Maine, Connecticut, California, Japan and China, and in remote locations around the world.
With a 2023 operating budget of $628M, JAX has substantial impact on our local communities.
Our research teams focus on cancer, immunology and autoimmune diseases (including diabetes), neuroscience and neurodegenerative diseases (including Alzheimer’s disease), life-cycle biology (including development, stem cells, aging and regenerative medicine), the microbiome and computational biology.
Multiple JAX research centers unite experts around critical research areas including cancer, aging, Alzheimer’s disease, addiction biology, precision genetics, rare and orphan diseases, vision and computational biology.
JAX has more than 60 faculty with independent research programs, and more than 400 JAX staff members hold Ph.D., M.D., D.V.M. or D.Sc. advanced degrees.
In 2022, JAX researchers were supported by $65.3 million in peer-reviewed research funding (annual direct costs).
JAX has had a National Cancer Institute-designated Cancer Center since 1983, and is one of only seven institutes in the United States that has received this designation for its contributions to basic cancer research.
Our researchers have made significant contributions to medical progress, including bone marrow and organ transplants, stem cell therapies and in vitro fertilization.
EDUCATION
We offer comprehensive educational programs for scientists throughout their careers, from high school students and teachers, to researchers at all experience levels, and for clinical providers interested in incorporating genetics and genomics into their practices.
RESOURCES
Over 2,400 organizations in 68 countries rely on over 13,000 strains of genetically-specialized JAX® Mice and research services in a wide range of therapeutic areas.